Beyond Air, Inc. (XAIR) Reports In-Line Q3 EPS, Beats on Revenue
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Super Micro Computer establishes $1.25 billion stock sale agreement
Beyond Air® Reports Fiscal Third Quarter 2025 Financial Results and Provides Corporate Update
February 10, 2025 4:05 PM ESTRevenues increased 34% compared to the previous quarter ended September 30, 2024; and exceeded $1 million
Received CE Mark for LungFit PH® in Europe and Market Authorization in Australia; international shipments to commence later this year
Conference call at 4:30 p.m. ET today, February 10th
GARDEN CITY, New York, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (Beyond Air or the Company), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve... More
